Associated Papers
Pirtobrutinib targets BTK C481S in ibrutinib-resistant CLL but second-site BTK mutations lead to resistance.
Naeem A et al.
Blood Advances, 2023
36287227 (PubMed )
Supplement: BLOODA_ADV-2022-008447-mmc1.xlsx › Table_S3
Whole-exome sequencing reveals the origin and evolution of hepato-cholangiocarcinoma.
Wang A et al.
Nature Communications, 2018
29497050 (PubMed )
Supplement: 41467_2018_3276_MOESM5_ESM.xlsx › ___1
Colorectal adenomas contain multiple somatic mutations that do not coincide with synchronous adenocarcinoma specimens.
Vaqué JP et al.
Plos One, 2015
25775023 (PubMed )
Supplement: pone.0119946.s007.xls › Hoja5
Select a paper to view details